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Abstract
Background: Although pneumonia is a leading cause of inpatient mortality, deaths may also occur after discharge
from hospital. However, prior studies have been small, in selected groups or did not fully evaluate risk factors,
particularly malnutrition and HIV. We determined 1-year post-discharge mortality and risk factors among
children diagnosed with severe pneumonia.
Methods: A cohort study of children aged 1–59 months admitted to Kilifi County Hospital with severe pneumonia
(2007–12). The primary outcome was death <1 year after discharge, determined through Kilifi Health and
Demographic Surveillance System (KHDSS) quarterly census rounds.
Results: Of 4184 children (median age 9 months) admitted with severe pneumonia, 1041 (25%) had severe acute
malnutrition (SAM), 267 (6.4%) had a positive HIV antibody test, and 364 (8.7%) died in hospital. After discharge,
2279 KHDSS-resident children were followed up; 70 (3.1%) died during 2163 child-years: 32 (95% confidence
interval (CI) 26, 41) deaths per 1000 child years. Post-discharge mortality was greater after admission for severe
pneumonia than for other diagnoses, hazard ratio 2.5 (95% CI 1.2, 5.3). Malnutrition, HIV status, age and
prolonged hospitalisation, but not signs of pneumonia severity, were associated with post-discharge mortality.
Fifty-two per cent (95% CI 37%, 63%) of post-discharge deaths were attributable to low mid-upper arm
circumference and 11% (95% CI 3.3%, 18%) to a positive HIV test.
Conclusions: Admission with severe pneumonia is an important marker of vulnerability. Risk stratification and
better understanding of the mechanisms underlying post-discharge mortality, especially for undernourished
children, are needed to reduce mortality after treatment for pneumonia.
Keywords: children, severe pneumonia, post-discharge, mortality.
Worldwide, pneumonia is the leading cause of death
for children <5 years and accounted for approxi-
mately 1.3 million deaths in 2011.1,2 Several studies
have examined inpatient treatment failure and death
amongst children with severe pneumonia.3–6 How-
ever, deaths are known to also occur after discharge
from hospital. A systematic review of paediatric post-
discharge mortality in resource-poor countries, identi-
fied 13 studies.7 Only three of these studies
specifically reported outcomes among children admit-
ted with pneumonia: from The Gambia (n = 118),
Bangladesh (n = 162), and Tanzania (n = 666).8–10
Two of the studies excluded children with severe
malnutrition or other co-morbidities,9,10 and one
examined the effect of HIV prior to widespread avail-
ability of antiretroviral therapy.10
Since the systematic review in 2013,7 three studies
reporting post-discharge mortality among children
admitted with pneumonia have been published.11–13
Two of these studies included hospitalised children
with a diagnosis of pneumonia, but not necessarily
severe pneumonia according to World Health
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Organization (WHO) guidelines, from The Gambia
(n = 2725)11 and Uganda (n = 389).12 Only the Ugan-
dan study12 examined the effect of HIV status. One
other study, from Bangladesh (n = 369)13 used WHO
diagnostic criteria for severe pneumonia, but only
included HIV-uninfected children with Severe Acute
Malnutrition (SAM). The duration of follow-up varied
between 3 months and more than 12 months, and
none adequately reported loss to follow-up or
expressed mortality as an incidence rate. Thus,
current knowledge of post-discharge mortality
following treatment from severe pneumonia, and its
risk factors, is limited.
We aimed to determine 1-year post-discharge mor-
tality rate and its risk factors amongst children consec-
utively admitted to a rural Kenyan hospital with
syndromically diagnosed severe pneumonia.14
Methods
Study setting
This was an observational cohort study. The study
was conducted at Kilifi County Hospital (KCH) in a
rural area on the Kenyan coast. Haemophilus influenzae
type b and pneumococcal conjugate vaccines were
introduced in November 2001 and February 2011,
respectively.15,16 The antenatal HIV prevalence is
4.9%.17 KCH provides inpatient and outpatient
services for HIV and malnutrition. Exposures were
clinical, laboratory, and demographic features at hos-
pitalisation. The primary outcome was death within
1 year after discharge from hospital. The study was
approved by the Kenya Medical Research Institute
(KEMRI) National Ethical Review Committee (SCC
2778).
Study population
We analysed systematically collected surveillance
data from all children aged 1 to 59 months admitted
to KCH between January 2007 and December 2012,
and followed up those resident in the Kilifi Health
and Demographic Surveillance System (KHDSS) until
April 2014. We initially included non-KHDSS resi-
dents in order to better understand the characteristics
and generalisability of the children who were fol-
lowed up in the context of all children served by the
hospital. Trained clinicians provided care according
to WHO guidelines.14
Clinical deﬁnitions and care
Severe pneumonia was defined by WHO (2005)14 as
cough or difficulty breathing plus either lower chest
wall indrawing or inability to breast feed/drink/
vomiting everything, impaired consciousness, central
cyanosis or peripheral oxygen saturation <90% by
pulse oximetry (Nelcor USA).3,14 Impaired conscious-
ness was defined as ‘prostration’ (inability to sit
unassisted at ≥1 year; inability to drink or breast feed
at <1 year) or ‘coma’ (Blantyre coma score ≤2). We
classified children as having the syndromes of severe
or very severe pneumonia, hereafter called ‘severe
pneumonia’ (including children who had an addi-
tional diagnosis), or not having severe pneumonia.
As previously described,18,19 trained clinical
assistants measured Mid-upper arm circumference
(MUAC) with a non-stretch measuring tape (TALC, St
Albans, UK), weight with an electronic scale (Seca,
Birmingham, UK) that was checked weekly for consis-
tency, and length using a measuring board of stan-
dard United Nation Children’s Fund (UNICEF)
design (for children younger than 2 years or those
who could not stand) or height using a wall-mounted
stadiometer (Seca, Birmingham, UK). Inpatient man-
agement of SAM was based on one or more of
weight-for-length z-score, MUAC or the presence
of kwashiorkor, and followed WHO guidelines.14
Children with SAM were discharged to therapeutic
and/or supplementary feeding programmes as per
national guidelines.
HIV testing using two rapid antibody tests, Deter-
mine (Inverness Medical, Florida, USA) and Unigold
(Trinity Biotech, Bray, Ireland), was systematically
offered to all paediatric admissions according to
national guidelines.20 Families of patients with a posi-
tive test were counselled and referred for comprehen-
sive care. Blood culture was systematically undertaken
by methods previously published.18 We defined severe
anaemia as haemoglobin <5 g/dL. As part of an
ongoing study, nasopharyngeal specimens were
systematically collected from children with severe
pneumonia and tested for respiratory syncytial virus
(RSV) using a Direct Immunofluorescent Antibody Test
(Chemicon, Temecula, CA).21,22 Nasopharyngeal sam-
ples were not collected in a high proportion of the most
severely ill children (i.e., those in the high dependency
ward), as previously reported.21 RSV was the only viral
pathogen more frequently detected in severe pneumo-
nia compared to controls without pneumonia.21
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Follow-up after discharge was done through the
KHDSS. Within the KHDSS, the community of
approximately 262 000 residents in an area of 891 km2
immediately surrounding the hospital has been allo-
cated unique identifiers that are matched when
patients are admitted to hospital. Households are enu-
merated by trained fieldworkers for vital events every
4 months, as described elsewhere.17
Statistical analysis
Participants were stratified either as residents of
KDHSS or non-residents. Outlying anthropometric
z-score values were excluded if their values were 6
from the median z-score for each anthropometric
parameter. This method differs from data cleaning
methods commonly applied to community surveys
(usually 3 z-score from the observed survey mean)23
because very low values were typically confirmed as
genuine within this range amongst this population of
children who were sick enough to be admitted to
hospital.
To determine post-discharge mortality, we used
KDHSS census data from January 2007 to April 2014.
The time at risk considered was from discharge to
365 days later, or the date of out-migration or death.
We performed a single discharge analysis, where only
the first admission during the study period was con-
sidered. Data from children with missing outcomes
were excluded. Absent HIV antibody and RSV test
data were analysed as separate categories as they
were assumed not to have been missed randomly.
Post-discharge mortality was reported as the inci-
dence rate per 1000 child-years of observation.
Variables were investigated as potential risk factors
for post-discharge mortality based on previous
work.3,24 A binary variable for previous admission
was used in the analysis since only 0.9% (22/2461) of
KHDSS-residents who were discharged alive had >1
prior admission. We plotted Kaplan—Meier curves
and used Cox proportional hazards models to test
associations with post-discharge mortality, retaining
all variables in the multivariable model. We tested for
interactions by comparing models using likelihood-
ratio tests. Survival distributions were compared
using the log-rank test. Goodness of fit was assessed
using correlation coefficient, R-squared and Akaike
information criterion.
Because of the anticipated role of undernutrition in
driving mortality, that stunting as well as thinness
may be associated with increased mortality risk, and
debate over which indices are most informative,25 we
built three multivariable models using different
anthropometric parameters: (i) using MUAC, which
captures elements of age, is less affected by dehydra-
tion than weight-based indices and appears to be
more reliable than calculated length-based z- scores in
young children;25–27 (ii) using both of the traditional
indicators of acute and chronic malnutrition, wasting
(weight-for-height z-score) and stunting (length or
height-for-age z-score); and (iii) using weight-for-age
z-score, which captures all factors affecting body-
weight.
Internal validation was done by calculating boot-
strapped area under the receiver operating curve
(AUROC) and bias-corrected 95% confidence intervals
estimated using a probit model, resampled 200 times
(with replacement). Population attributable fractions
(PAF) were calculated28 and adjusted for age, gender,
and HIV status.
Results
Overall, 4184 children (1–59 months) were admitted
with severe pneumonia, comprising 32% of all
admissions within the study age range (Figure 1).
Their median age (IQR) was 8.9 (4 to 19) months;
578 (14%) were hypoxic at admission, 1041 (25%)
were severely malnourished, and 267 (6.4%) had a
positive HIV antibody test (Table 1). Three hun-
dred and sixty-four (8.7%) children with severe
pneumonia died in hospital (55% of inpatient
deaths within this age range) compared with 296/
8908 (3.3%) amongst all children admitted without
severe pneumonia (age-adjusted relative risk (RR)
2.6, 95% CI 2.3, 3.1). Within the KHDSS, children
admitted with severe pneumonia had more severe
disease and co-morbidities than children admitted
without severe pneumonia. There were 137/2461
(5.6%) inpatient deaths among children admitted
with severe pneumonia compared to 125/5270
(2.4%) among children admitted without severe
pneumonia within KHDSS [age-adjusted relative
risk [RR] 2.3, (95% CI 1.8, 2.9)].
Amongst children admitted with severe pneumo-
nia, non-KHDSS residents had more severe disease
and more co-morbidities than KHDSS residents
(Table S1). Overall, 137/2461 (5.6%) KHDSS-residents
died in hospital compared to 227/1723 (13.2%) non-
KHDSS residents (RR 0.4, 95% CI 0.34, 0.52).
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Two thousand two hundred and seventy-nine
KHDSS-resident children with severe pneumonia
were discharged alive and followed up for 1 year, giving
2163 child-years, during which 70 (3.1%) children
died (Figure 1). Twenty-six (37%) of the 70 deaths
occurred during a subsequent hospital admission.
Post-discharge deaths comprised 70/207 (34%) of all
inpatient and post-discharge deaths amongst KHDSS-
resident children admitted with severe pneumonia.
Six (8.6%), 19 (27%), 31 (44%), and 52 (74%) post-
discharge deaths occurred within 7, 30, 90, and
180 days, respectively. The post-discharge mortality
rates from discharge to months 3, 6, and 12 were 144
(95% CI 101, 205), 65 (95% CI 49, 86), and 32 (95% CI
26, 41) deaths per 1000 child-years, respectively.
For comparison, of 5099 KHDSS-resident children
admitted during the same period without severe
pneumonia, 65 (1.3%) children died within 1-year
post-discharge (4898 child years): 13 (95% CI 10, 17)
deaths per 1000 child years. Thus, severe pneumonia
comprised 70/135 (52%) of all post-discharge deaths.
Children admitted with severe pneumonia had a
higher risk of post-discharge mortality than children
admitted without severe pneumonia (age adjusted
hazard ratio 2.50 (95% CI 1.17, 5.32) (Figure 2a).
Within the severe pneumonia cohort, young age,
nutritional status, HIV status, and prolonged duration
of hospitalisation, were associated with post-
discharge mortality (Table 2, Tables S2, S3, S4 and
Figure 2b, c and d). Severe underweight (weight-for-age
z-score <3) and a positive HIV test were present in
38 (54%) and 16 (23%) of the 70 children who died
post-discharge. Eight (11%) children who died had
both severe underweight and a positive HIV test.
Distance from the hospital was associated with post-
discharge mortality in the univariable model, but the
effect was not evident in the multivariable model
(Table 2, Tables S2, S3). We found interaction between
HIV status and weight-for-height z-score (P < 0.01)
but no interaction with height-for-age z-score
(P = 0.42), weight-for-age z-score (P = 0.31), or
MUAC (P = 0.63). The effect of nutritional status on
post-discharge mortality was attenuated slightly after
adjusting for HIV status (Table S4). There was no evi-
dence of interaction between age and MUAC
(P = 0.27), weight-for-height z-score (P = 0.09) or HIV
Figure 1. Recruitment and follow-up.
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status (P = 0.47) on post-discharge mortality. How-
ever, we found interaction between age and height-
for-age z-score (P < 0.01) on post-discharge mortality.
In the model with wasting and stunting, the predomi-
nant effect was from stunting (Table S3). The boot-
strapped AUROCs for the final models were similar
to the original models based on MUAC (Table 2),
wasting and stunting, and weight-for-age z-score
(Table S3).
For individual anthropometric indices, the perfor-
mance of MUAC and weight-for-age did not differ
(Table S4), whilst weight-for-length/height and
length/height-for-age performed less well than
MUAC in predicting post-discharge mortality.
Among the 1979 children with no SAM, a total of
14 (0.7%), 20 (1.0%), and 24 (1.2%) children died dur-
ing months 3, 6, and 12 of follow-up, respectively.
While 22 (7.3%), 32 (11%), and 46 (15%) children died
within months 3, 6, and 12 respectively among SAM
children. MUAC <11.5 cm alone (indicative of severe
malnutrition) was strongly associated with post-
discharge mortality (Figure 2c). Among children with
Table 1. Patient characteristics at admission
All severe pneumonia
admissions (n = 4184)
Severe pneumonia admissions
among KHDSS Residents
(n = 2461)
Admission without severe
pneumonia among KHDSS
Residents (n = 5270)
Demographic characteristicsa
Age in months: median (IQR) 8.9 (4, 19) 9.3 (3.9, 20.4) 19.5 (11, 28.5)
Female 1846 (44) 1064 (43) 2297 (44)
Reported preterm/LBW 166 (4.0) 74 (3.0) 108 (2.1)
Hospitalization time (days): median (IQR) 4 (2, 6) 3 (2, 5) 3 (2, 6)
Previous hospital admission 109 (2.6) 69 (2.8) 128 (2.4)
Clinical characteristics at admission
Hypoxia (SaO2 <90%) 578 (14) 304 (12) 73 (1.4)
Capillary refill >2 s 202 (4.8) 89 (3.6) 116 (2.2)
Impaired consciousnessb 329 (7.9) 161 (6.5) 234 (4.4)
Wheezing 671 (16) 432 (18) 27 (0.5)
Cough for >14 days 185 (4.8) 68 (3.0) 117 (6.9)
Jaundice 34 (0.8) 15 (0.6) 73 (1.4)
Severe anaemia 114 (3.4) 59 (3.0) 174 (3.3)
Axillary temperature <36°C 112 (2.7) 71 (2.9) 172 (3.3)
Axillary temperature 36–39°C 3355 (80) 1988 (81) 4159 (79)
Axillary temperature >39°C 717 (17) 402 (16) 939 (18)
HIV antibody test positive 267 (6.4) 110 (4.5) 145 (2.8)
HIV test not performed 307 (7.3) 180 (7.3) 634 (12)
RSV test positive 805 (19) 485 (20) 9 (0.2)
RSV test not performed 1109 (27) 723 (29) 5146 (98)
Malaria slide positive 401 (9.6) 240 (9.8) 1203 (23)
Bacteraemia 189 (4.5) 113 (4.6) 308 (5.8)
Nutritional characteristics at admission
WHZMean (sd)c 1.1 (1.8) 0.9 (1.7) 1.1 (1.5)
HAZ Mean (sd)d 1.6 (1.7) 1.5 (1.6) 1.7 (1.6)
WAZMean (sd)e 1.9 (1.7) 1.7 (1.6) 1.7 (1.4)
HCAZMean (sd)f 0.5 (1.7) 0.4 (1.6) 0.5 (1.5)
MUAC cmMedian (IQR)g 13.0 (11.8, 14.0) 13.0 (12.0, 14.2) 14.0 (12.6, 14.9)
Kwashiorkor (nutritional oedema) 68 (1.6) 25 (1.0) 234 (4.5)
Outcome
Inpatient death 364 (8.7) 137 (5.6) 126 (2.4)
adata given as N (%) unless otherwise indicated, IQR: interquartile range, LBW: low birthweight (<2500 g), bconscious level classified as
‘prostrate’ or ‘unconscious’, RSV: Respiratory Syncytial Virus, e115 missing, d378 missing, c454 missing, f168 missing, sd: Standard devi-
ation, g161 missing, WHZ: weight for length/height z-score, HAZ: length/height for age z-score, WAZ: weight for-age z-score, HCAZ:
head circumference for age z-score, MUAC: Mid-upper arm circumference, and KHDSS: Kilifi Health and Demographic Surveillance
System.
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MUAC <11.5 cm, 14.0% died within 1 year. This con-
trasts with non-malnourished children with MUAC
≥13.5 cm, among whom 1.0% died within 1 year
(adjusted HR 11.8, 95% CI 5.7, 24.5) (Table S4).
After adjusting for age, HIV status, and gender, the
fractions of post-discharge mortality attributable to
MUAC <13.5 cm; weight-for-length/height z-score
<1; weight-for-age z-score <1; and height/length-for-
age z-score <1 were 52% (95% CI 37, 63); 13% (95% CI
3.2, 22); 57% (95% CI 42, 68); and 34% (95% CI 18, 46),
respectively. The fraction of post-discharge deaths
accounted for by a positive HIV test was 11% (95% CI
3.3, 18) after adjusting for age, gender, and MUAC.
Comment
Amongst Kenyan children (1–59 months), admitted to
hospital, approximately a third of deaths in children
admitted with severe pneumonia and followed up for
12 months occurred after discharge. The risk of post-
discharge mortality amongst children admitted with
severe pneumonia was more than twice that of those
admitted with other conditions. We had previously
reported data from a large clinical trial showing a sim-
ilar relationship between clinical syndrome at the
index admission and post-discharge mortality
amongst HIV-uninfected children with SAM,29 the
current results extend this phenomenon to all admis-
sions. Thus, admission with severe pneumonia can be
regarded as an important marker of vulnerability,
partly because it captures effects of common co-
morbidities. Malnutrition, rather than HIV, was the
predominant risk factor for post-discharge mortality,
despite the provision of outpatient treatment services
for malnutrition.
We found an inpatient case fatality ratio for severe
pneumonia of 8.7%, which is much higher than the
most recent regional estimate of case fatality for
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Figure 2. Hazards of post-discharge death associated with (a) severe pneumonia vs. other diagnoses; (b) age at admission; (c) MUAC at
admission; and (d) HIV status.
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Africa, derived from 11 studies, of 3.9%.30 This was
despite an increase in staffing, an ensured supply of
essential drugs, and careful adherence to WHO treat-
ment guidelines because of the presence of the
research centre. These findings concord with the inpa-
tient case fatality ratio of 9.8% reported at district hos-
pitals throughout Malawi following an intervention to
improve case management,31 and suggest the need to
investigate new treatment strategies.
Nutritional status was the major driver of post-
discharge mortality. MUAC was an efficient single
marker of mortality risk, performing better than
weight-for-height z-score, the traditional marker of
acute malnutrition, including after adjustment for age
and gender which are known confounders of
MUAC.25,27 It could be argued that because MUAC
changes with age, it predominantly captures the
youngest children, rather than nutritional status.
However, mortality was far higher amongst all chil-
dren with MUAC <11.5 cm than amongst those who
were simply aged under 6 months (Figure 2b and c)
and the relationship between MUAC and mortality
appeared to be less confounded by age than other
nutritional indices. Weight-for-age performed as well
as MUAC in predicting post-discharge mortality in
our study and previously was identified as a strong
predictor of mortality in the community.32 Weight-
for-age is not currently used to define acute malnutri-
tion, but could be used as an alternative indicator.
Height-for-age z-score (stunting) also predicted post-
discharge mortality (Table S4), possibly reflecting
chronic disadvantage and ill-health.
Our findings concur with data from Bangladesh13
in suggesting that children who died after admission
were younger and more severely malnourished. The
proportions (7.3% and 11%) of severely malnourished
children with severe pneumonia who died within 3
and 6 months after discharge were also very similar
to published data from Gambia and Bangladesh.11,13
Likewise, amongst children without malnutrition, our
finding of ~1% who died post-discharge also was very
similar to studies in Gambia and Bangladesh,9,11 sug-
gesting generalisability when stratified by nutritional
status, despite the potential limitations of our study
outlined below.
We observed that post-discharge mortality was not
associated with hypoxia or other signs of acute sever-
ity, as previously has been reported from The Gambia.8
This is likely to be because children with severe signs
more often died during the inpatient phase. However,
Table 2. Multivariable analysis of factors associated with 1-year
post-discharge mortality among KHDSS residents (n = 2279)
(Child years of observation
(cyo)=2163)
Number
(Mortality rate
per 1000cyo)
Adjusted
HR (95% CI)
Demographic characteristics
Age in months
≥24 months 401 (12.4) 1.0 (Reference)
12–23 months 546 (13.8) 1.0 (0.1, 9.6)
6–11 months 519 (27.2) 5.8 (0.8, 40.5)
<6 months 813 (57.2) 4.8 (0.7, 34.1)
Female 976 (29.1) 0.5 (0.3, 1.1)
Reported preterm/LBW 64 (99.5) 0.7 (0.2, 2.8)
Residence distance
from KCH per km
2117 1.0 (0.9, 1.1)
Duration of hospitalization
per day
2276 1.1 (1.0, 1.2)
Clinical characteristics at admission
Hypoxia (SaO2 <90%) 247 (87.9) 1.9 (0.7, 5.4)
Capillary refill >2 s 48 (188.3) 2.4 (0.5, 12.1)
Impaired consciousnessa 103 (71.6) 1.1 (0.2, 7.8)
Wheezing 424 (9.6) 0.5 (0.1, 2.4)
Cough for >14 days 55 (92.7) 0.2 (0.1, 5.5)
Jaundice 13 (75.5) 12.5 (1.1, 13.7)
Severe anaemia
(Hb <5 g/dL)
48 (42.7) 0.8 (0.1, 7.5)
Axillary temperature <36°C 58 (35.4) 0.3 (0.1, 2.8)
Axillary temperature
36 to 39°C
1858 (30.9) 1.0 (Reference)
Axillary temperature >39°C 363 (24.5) 1.1 (0.4, 3.0)
HIV antibody test negative 2035 (25.1) 1.0 (Reference)
HIV antibody test positive 85 (202.6) 6.5 (2.3, 18.4)
HIV test not performed 159 (17.3) 0.4 (0.1, 3.6)
RSV test negative 1174 (32.5) 1.0 (Reference)
RSV test positive 477 (13.1) 0.3 (0.1, 1.2)
RSV test not performed 628 (34.5) 2.7 (1.2, 6.3)
Malaria slide negative 2073 (32.6) 1.0 (Reference)
Malaria slide positive 206 (5.3) 0.5 (0.1, 5.2)
No bacteraemia 2187 (29.2) 1.0 (Reference)
Bacteraemia 92 (43.5) 0.8 (0.1, 5.2)
MUAC per cm 2218 0.6 (0.5, 0.8)
Year of admission
2007 480 (27.0) 1.0 (Reference)
2008 381 (31.4) 0.9 (0.3, 3.1)
2009 392 (19.9) 0.5 (0.1, 2.1)
2010 392 (28.5) 0.7 (0.2, 2.5)
2011 319 (35.2) 1.7 (0.5, 5.3)
2012 315 (41.6) 1.8 (0.2, 15.7)
Model performance
AIC 526.9
Raw AUC (95% CI) 0.91 (0.88, 0.95)
Bootstrapped AUC (95% CI) 0.92 (0.88, 0.96)
aconscious level classified as ‘prostrate’ or ‘unconscious’, RSV:
Respiratory Syncytial Virus, MUAC: mid-upper arm circumfer-
ence, LBW: Low birthweight (<2.5 kg), AIC: Akaike information
criterion, AUC: area under the receiver operating characteristics
curve.
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in Uganda, in a study where severe pneumonia was
not strictly defined according to WHO criteria, two fea-
tures of severity, oxygen saturation and coma score
were associated with post-discharge mortality after
adjustment for HIV and nutritional status.12
The strengths of this study were its large sample
size; systematically collected data at admission to hos-
pital, including prospective anthropometry and HIV
status; and a long duration of follow-up by systematic
census with limited missing outcomes. An important
limitation is that it includes only a subset of KHDSS-
resident children at a single site. Non-KHDSS resident
children had a higher prevalence of predictive
co-morbidities, a lower level of access and a higher
inpatient case fatality ratio that suggest that their
post-discharge mortality is likely to be higher than
that of KHDSS resident children. Other sites in lower
middle income countries (LMICs) may also differ in
relation to factors including immunization, access to
health care services, and the prevalence of HIV, and
facilities for its treatment. We were not able to assess
the impact of tuberculosis (TB) contact or antiretrovi-
ral therapy or co-trimoxazole prophylaxis in post-
discharge mortality amongst HIV-infected children.
Our investigation of variables potentially associated
with post-discharge mortality was guided by prior
reports, but could have resulted in over-fitting.
An inherent limitation is that the clinical syndrome
of severe pneumonia is sensitive rather than specific
for radiologically defined pneumonia and death. It
captures other respiratory tract infections such as
bronchiolitis or tuberculosis,33 as well as respiratory
distress due to sepsis or malaria. However, it reflects
the diagnostic criteria typically used in similar set-
tings. It is also possible that some children with severe
pneumonia were excluded from our study if they did
not exhibit the usual clinical signs of pneumonia,
which may occur more frequently amongst malnour-
ished children.34
Further research is needed to examine the mecha-
nisms of post-discharge mortality, including the roles
of ability to access health care, maternal mental and
physical health, HIV care, undetected TB and the
extent to which nosocomial acquisition of resistant
pathogens may contribute to the mortality observed.
Conclusions
In rural Kenya, the majority of inpatient and post-
discharge child deaths were associated with severe
pneumonia, often in children with underlying co-
morbidities. In this study and in prior studies, where
assessed, anthropometric markers of malnutrition
were consistently the principal driver of mortality.
Post-discharge mortality is under-recognised within
treatment guidelines and practice. Risk stratifica-
tion and a better understanding of the mechanisms
underlying post-discharge mortality, especially for
undernourished children, are needed to reduce mor-
tality after treatment for pneumonia.
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